Walnut, CA—Farlong Pharmaceutical has announced the results of a study examining the effects of its branded notoginseng extract on cholesterol and blood pressure. The randomized, placebo-controlled, triple-blind study was published in Current Nutraceuticals Journal. It was performed on 95 healthy adults. The study demonstrated that Farlong NotoGinseng supplementation improved blood...
Walnut, CA—Farlong Pharmaceutical has completed a three-year clinical trial to determine the effects of Farlong NotoGinseng, according to a press release. The randomized, placebo-controlled, double-blind, parallel study was performed on 100 adults between December 2016 and June 2019. It sought to determine the effect of Farlong’s branded Panax notoginseng extract...
Austin, TX—The American Botanical Council (ABC) announced in a press release that Farlong Pharmaceutical, an herbal ingredient and supplement company based in California, adopted both notoginseng and lifeflower through ABC’s Adopt-an-Herb Program. Adoption helps ABC expand its nonprofit research and educational mission and keep its HerbMedPro database updated with the...
